US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 1, 2020
Clear
SKU: GMS-1301 Category:

The US market for anticoagulation therapy is projected to hit USD 33.34 billion by 2024, growing over the forecast period at a CAGR of 7.6%. Market growth is driven primarily by the increasing incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurrent drug sales; and increased demand for novel oral anticoagulants (NOACs).

US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) - 2019 to 2024 1

US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) - 2019 to 2024 2

US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) - 2019 to 2024 3

US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) - 2019 to 2024 4

US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) - 2019 to 2024 5

US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) - 2019 to 2024 6

US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) - 2019 to 2024 7

US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) - 2019 to 2024 8
US Anticoagulation Therapy Market by Type of Clinic (Independent & Pharmacy-based, Hospital Associated), Product (Anticoagulants Drugs, PT/INR Devices ), Service Type (Consulting and Testing) - 2019 to 2024 7

1 US Anticoagulation Therapy Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 US Anticoagulation Therapy Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 US Anticoagulation Therapy Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 US Anticoagulation Therapy Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 US Anticoagulation Therapy Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 US Anticoagulation Therapy Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 US Anticoagulation Therapy Market – By Type of Service (Market Size – & million/billion)
8.1 Testing Services
8.2 Consulting Services

9 US Anticoagulation Therapy Market – By Type of Clinic
9.1 Hospital Associated Clinics
9.2 Independent Clinics
9.3 Pharmacy-Based Clinics

10 US Anticoagulation Therapy Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 US Anticoagulation Therapy Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 US Anticoagulation Therapy Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Abbott Laboratories
12.3 Siemens AG
12.4 Coagusense, Inc.
12.5 Alere Inc.
12.6 C. H. Boehringer Sohn AG & Co. Kg
12.7 Bristol-Myers Squibb Company
12.8 Johnson & Johnson
12.9 Pfizer, Inc.
12.10 Daiichi Sankyo Company, Limited
12.11 Portola Pharmaceuticals, Inc.
12.12 Company 11 & more

13 US Anticoagulation Therapy Market – Appendix
13.1 Sources
13.2 Abbreviations